Trends in the Genomic Sequencing Technology Market
A Survey of Lab Directors
Deliverable: PowerPoint with Key Findings.
Study Description:
|
Topic |
DNA Sequencing Survey |
|
Respondent Type |
Lab Directors |
|
Specialties Covered |
Other |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 20 minutes Size: 22 respondents Fielding Dates: September 13, 2007 to September 23, 2007 |
Objectives:
Primary objectives are to better understand customer perception of the next generation sequencing market; the competitive dynamics within the microarray market; as well as the potential impact of next generation sequencing on demand for microarrays and other related products.
§ To address the following topics with regard to the next generation sequencing market:
· Primary drivers for adoptions (i.e. throughput, read length, cost of data, ease of use, instrument footprint, etc.).
· Companies perceived as having the best technology/utility for research needs (i.e. criteria for next generation sequencing).
· Systems purchased or intentions to buy (which vendors and why, how many).
· Applications most likely to be used in the near medium term (0-5 years).
· For those with first hand experience, any unanticipated benefits or problems associated with the next gen platform (i.e. higher data migration costs, etc.)
§ To address the following topics with regard to the microarray market:
· Perception and purchasing intentions for competitive products (AFFX vs. ILMN vs. A) – in particular, specific color related to new product launches (AFFX 6.0, ILMN 1M DNA Analysis BeadChip).
· Applications mostly used, fastest growing areas (methylation, CHIP-chip, etc.).
· Impact of next generation sequencing on demand for microarrays and other products.
· Perception of other emerging technologies – Multiplex RT-PcR (Fluidigm, BioTrove), artificial DNA (Codon), etc.
Inclusion Criteria and Respondent Demographics:
|
Inclusion Criteria
|
§ Lab directors or comparably high-level individuals involved in DNA sequencing and analysis. § Involved with large capital purchasing decisions. § Lab must have annual budget of $500,000 - $10,000,000. § Have first-hand experience or knowledge of next generation sequencing technologies. |
To purchase this report or request additional information, contact:
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |